Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.

Allospecific immune responses against the MHC of another individual are remarkably strong, due t a high number of responding T cell clones. Although it has been demonstrated that some allospecific cytotoxic T lymphocytes (CTL) recognize peptides presented by allogeneic MHC class I molecules, it has...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Aosai, F, Ohlen, C, Ljunggren, H, Höglund, P, Franksson, L, Ploegh, H, Townsend, A, Kärre, K, Stauss, H
التنسيق: Journal article
اللغة:English
منشور في: 1991
_version_ 1826274580673593344
author Aosai, F
Ohlen, C
Ljunggren, H
Höglund, P
Franksson, L
Ploegh, H
Townsend, A
Kärre, K
Stauss, H
author_facet Aosai, F
Ohlen, C
Ljunggren, H
Höglund, P
Franksson, L
Ploegh, H
Townsend, A
Kärre, K
Stauss, H
author_sort Aosai, F
collection OXFORD
description Allospecific immune responses against the MHC of another individual are remarkably strong, due t a high number of responding T cell clones. Although it has been demonstrated that some allospecific cytotoxic T lymphocytes (CTL) recognize peptides presented by allogeneic MHC class I molecules, it has remained unclear whether MHC molecules can be recognized directly. We used the H-2b-derived murine lymphoma mutant RMA-S, which has a defect affecting peptide loading of class I molecules, to test whether recognition by allospecific CTL always requires the presence of peptides. Three types of anti-H-2Kb CTL clones can be distinguished by their ability to lyse RMA-S target cells. Type A CTL clones efficiently lyse these target cells, the lysis by type B CTL clones is inefficient, and type C clones fail to lyse RMA-S. Up-regulation of the levels of H-2Kb density improved lysis by type B clones, but did not lead to lysis by type C clones. Some type A and B CTL clones apparently can recognize class I molecules devoid of peptides, while others are likely to recognize peptides which are not affected by the presentation defect of RMA-S. We suggest that type C clones are specific for peptides which are not presented by the mutant cells. The results show that the majority of alloreactive CTL recognize peptide/MHC complexes, while some CTL behave as if they can recognize class I molecules in the absence of MHC-bound peptides.
first_indexed 2024-03-06T22:45:36Z
format Journal article
id oxford-uuid:5d0ebee7-a20b-49fa-ab80-87ec0cd5a8f7
institution University of Oxford
language English
last_indexed 2024-03-06T22:45:36Z
publishDate 1991
record_format dspace
spelling oxford-uuid:5d0ebee7-a20b-49fa-ab80-87ec0cd5a8f72022-03-26T17:32:02ZDifferent types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5d0ebee7-a20b-49fa-ab80-87ec0cd5a8f7EnglishSymplectic Elements at Oxford1991Aosai, FOhlen, CLjunggren, HHöglund, PFranksson, LPloegh, HTownsend, AKärre, KStauss, HAllospecific immune responses against the MHC of another individual are remarkably strong, due t a high number of responding T cell clones. Although it has been demonstrated that some allospecific cytotoxic T lymphocytes (CTL) recognize peptides presented by allogeneic MHC class I molecules, it has remained unclear whether MHC molecules can be recognized directly. We used the H-2b-derived murine lymphoma mutant RMA-S, which has a defect affecting peptide loading of class I molecules, to test whether recognition by allospecific CTL always requires the presence of peptides. Three types of anti-H-2Kb CTL clones can be distinguished by their ability to lyse RMA-S target cells. Type A CTL clones efficiently lyse these target cells, the lysis by type B CTL clones is inefficient, and type C clones fail to lyse RMA-S. Up-regulation of the levels of H-2Kb density improved lysis by type B clones, but did not lead to lysis by type C clones. Some type A and B CTL clones apparently can recognize class I molecules devoid of peptides, while others are likely to recognize peptides which are not affected by the presentation defect of RMA-S. We suggest that type C clones are specific for peptides which are not presented by the mutant cells. The results show that the majority of alloreactive CTL recognize peptide/MHC complexes, while some CTL behave as if they can recognize class I molecules in the absence of MHC-bound peptides.
spellingShingle Aosai, F
Ohlen, C
Ljunggren, H
Höglund, P
Franksson, L
Ploegh, H
Townsend, A
Kärre, K
Stauss, H
Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
title Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
title_full Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
title_fullStr Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
title_full_unstemmed Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
title_short Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
title_sort different types of allospecific ctl clones identified by their ability to recognize peptide loading defective target cells
work_keys_str_mv AT aosaif differenttypesofallospecificctlclonesidentifiedbytheirabilitytorecognizepeptideloadingdefectivetargetcells
AT ohlenc differenttypesofallospecificctlclonesidentifiedbytheirabilitytorecognizepeptideloadingdefectivetargetcells
AT ljunggrenh differenttypesofallospecificctlclonesidentifiedbytheirabilitytorecognizepeptideloadingdefectivetargetcells
AT hoglundp differenttypesofallospecificctlclonesidentifiedbytheirabilitytorecognizepeptideloadingdefectivetargetcells
AT frankssonl differenttypesofallospecificctlclonesidentifiedbytheirabilitytorecognizepeptideloadingdefectivetargetcells
AT ploeghh differenttypesofallospecificctlclonesidentifiedbytheirabilitytorecognizepeptideloadingdefectivetargetcells
AT townsenda differenttypesofallospecificctlclonesidentifiedbytheirabilitytorecognizepeptideloadingdefectivetargetcells
AT karrek differenttypesofallospecificctlclonesidentifiedbytheirabilitytorecognizepeptideloadingdefectivetargetcells
AT staussh differenttypesofallospecificctlclonesidentifiedbytheirabilitytorecognizepeptideloadingdefectivetargetcells